勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].
出版信息
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
Abstract
[This corrects the article on p. 2543 in vol. 11, PMID: 27785010.].
摘要
[这纠正了第11卷第2543页上的文章，PMID: 27785010。]
相似文献
1
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
2
Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.茚达特罗加格隆溴铵对肺气肿充气过度合并 COPD 患者心室充盈的影响（CLAIM）：一项双盲、随机、交叉、安慰剂对照、单中心试验。
Lancet Respir Med. 2018 May;6(5):368-378. doi: 10.1016/S2213-2600(18)30054-7. Epub 2018 Feb 21.
3
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients.茚达特罗与格隆溴铵固定剂量复方制剂（QVA149）、其单一组分以及噻托溴铵与安慰剂在慢性阻塞性肺疾病（COPD）患者中的汇总安全性分析。
Respir Med. 2014 Oct;108(10):1498-507. doi: 10.1016/j.rmed.2014.07.011. Epub 2014 Aug 4.
4
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.茚达特罗/格隆溴铵（IND/GLY）在慢性阻塞性肺疾病（COPD）患者中的群体药代动力学
Int J Clin Pharmacol Ther. 2016 Jun;54(6):405-15. doi: 10.5414/CP202558.
5
Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].勘误：噻托溴铵/奥达特罗与噻托溴铵治疗日本慢性阻塞性肺疾病患者的疗效比较：DYNAGITO研究结果[勘误]
Int J Chron Obstruct Pulmon Dis. 2018 Oct 30;13:3587. doi: 10.2147/COPD.S191099. eCollection 2018.
6
Computed tomography (CT)-assessed bronchodilation induced by inhaled indacaterol and glycopyrronium/indacaterol in COPD.慢性阻塞性肺疾病（COPD）患者吸入茚达特罗和格隆溴铵/茚达特罗后计算机断层扫描（CT）评估的支气管扩张情况
Respir Med. 2016 Oct;119:70-77. doi: 10.1016/j.rmed.2016.08.020. Epub 2016 Aug 23.
7
8
Erratum: Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE [Corrigendum].勘误：沙美特罗/丙酸氟替卡松50/250联合噻托溴铵三联疗法与单独治疗相比可改善中重度日本慢性阻塞性肺疾病患者的肺功能：一项随机对照试验——三联治疗后气道比传导率的评估[勘误]
Int J Chron Obstruct Pulmon Dis. 2016 May 17;11:1031-1033. doi: 10.2147/COPD.S108620. eCollection 2016.
9
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Jul 22;9:1365. doi: 10.2147/OPTH.S91388. eCollection 2015.
10
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Mar 9;9:453. doi: 10.2147/OPTH.S81448. eCollection 2015.
Zotero 插件